Back to Results
First PageMeta Content
Biotechnology / Cell biology / Emerging technologies / Childbirth / Cell therapy / Cord blood bank / Dendreon / Cord blood / Stem cell / Biology / Medicine / Stem cells


Developing GMP IPS Lines - Identifying and Eliminating Roadblocks Mahendra Rao, M.D., Ph.D., (former) Director NIH CRM, Laboratory of Stem Cell Biology Chief, The Path to Personalized Medicine
Add to Reading List

Document Date: 2015-02-11 15:14:18


Open Document

File Size: 3,07 MB

Share Result on Facebook

Company

Dendreon / NeuralStem / Neural Products Stem Cell Inc / Sanofi / Cytori / Organgenesis Cord / Stratatech / Provenge Sanofi/Aastron / Tissue Genesis Wake Forest Biomedical Technologies / Genzyme / /

Country

United States / /

Facility

Pharma vs hospital / /

IndustryTerm

cultured blood product / manufacturing domain / manufacturing industry / transportation / printing / e-ink / bank / human gene therapy product / gene therapy products / manufacturing cells / manufacturing science / manufacturing / manufacturing site / blood banks / type product / marrow processing facilities / manufacturing process / /

MedicalCondition

cancer / graft-versus-host disease / heart disease / AIDS / infectious diseases / cystic fibrosis / hemophilia / /

MedicalTreatment

gene therapy / Cell Therapy / /

Organization

Laboratory of Stem Cell Biology / National Institute of Health / federal government / FDA / /

Person

Eliminating Roadblocks Mahendra Rao / Francis S. Collins / Margaret A. Hamburg / Cord Blood / /

Position

Director / Chief / /

Technology

gene therapy / CRM / Cell Therapy / Tissue Engineering / /

SocialTag